Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
119.31%
-
Total 13F principal
-
$434,295,986
-
Principal change
-
-$6,942,719
-
Total reported market value
-
$517,998,000
-
Number of holders
-
40
-
Value change
-
-$9,148,146
-
Number of buys
-
13
-
Number of sells
-
18
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q3 2016
As of 30 Sep 2016,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$434,295,986
in principal (par value) of the bond.
The largest 10 bondholders included
ZAZOVE ASSOCIATES LLC, Allianz Asset Management GmbH, VICTORY CAPITAL MANAGEMENT INC, AXA, ADVENT CAPITAL MANAGEMENT /DE/, FMR LLC, WELLS FARGO & COMPANY/MN, MACKAY SHIELDS LLC, PRUDENTIAL PLC, and Invesco Ltd..
This page lists
40
institutional bondholders reporting positions
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.